ERA 📈 Eramet SA - Overview
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0000131757
ERA: Manganese, Nickel, Ferronickel, Alloys, Steel, Titanium, Minerals
ERAMET S.A. operates as a mining and metallurgical company in France, Asia, Europe, North America, and internationally. The company extracts and processes manganese ore and nickel ore; and extracts and develops mineral sands. It also produces ferronickel, nickel pig iron, briquettes, nickel salts, high purity nickel, nickel ferroalloys, and alloy steel and casting; manganese alloys, such as high-carbon ferromanganese, silicomanganese, low and medium-carbon ferromanganese, and low-carbon silicomanganese for use in batteries, pigments, construction, and automotive industries; and mineral sands, such as titanium dioxide, high-purity pig iron, zircon, and ilmenite used in ceramics and pigments. In addition, it operates Moanda mine in Gabon; nickel mines in New Caledonia and Indonesia; and mineral sand mine in Senegal and Argentina. ERAMET S.A. was incorporated in 1880 and is headquartered in Paris, France. Web URL: https://www.eramet.com/en
Additional Sources for ERA Stock
ERA Stock Overview
| Market Cap in USD | 1,524m |
| Sector | Basic Materials |
| Industry | Other Industrial Metals & Mining |
| GiC Sub-Industry | Diversified Metals & Mining |
| IPO / Inception |
ERA Stock Ratings
| Growth 5y | 21.5% |
| Fundamental | 7.46% |
| Dividend | 37.5% |
| Rel. Strength Industry | -19896 |
| Analysts | - |
| Fair Price Momentum | 44.66 EUR |
| Fair Price DCF | - |
ERA Dividends
| Dividend Yield 12m | 2.94% |
| Yield on Cost 5y | 3.69% |
| Annual Growth 5y | 42.29% |
| Payout Consistency | 60.6% |
ERA Growth Ratios
| Growth Correlation 3m | -73.1% |
| Growth Correlation 12m | -30% |
| Growth Correlation 5y | 58% |
| CAGR 5y | 4.78% |
| CAGR/Mean DD 5y | 0.14 |
| Sharpe Ratio 12m | -0.57 |
| Alpha | -47.88 |
| Beta | 0.75 |
| Volatility | 48.28% |
| Current Volume | 52.7k |
| Average Volume 20d | 57.8k |
What is the price of ERA stocks?
As of December 21, 2024, the stock is trading at EUR 51.55 with a total of 52,738 shares traded.
Over the past week, the price has changed by -5.38%, over one month by -5.64%, over three months by -21.82% and over the past year by -29.88%.
As of December 21, 2024, the stock is trading at EUR 51.55 with a total of 52,738 shares traded.
Over the past week, the price has changed by -5.38%, over one month by -5.64%, over three months by -21.82% and over the past year by -29.88%.
Is Eramet SA a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Eramet SA is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 7.46 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ERA as of December 2024 is 44.66. This means that ERA is currently overvalued and has a potential downside of -13.37%.
Neither. Based on ValueRay Fundamental Analyses, Eramet SA is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 7.46 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ERA as of December 2024 is 44.66. This means that ERA is currently overvalued and has a potential downside of -13.37%.
Is ERA a buy, sell or hold?
Eramet SA has no consensus analysts rating.
Eramet SA has no consensus analysts rating.
What are the forecast for ERA stock price target?
According to ValueRays Forecast Model, ERA Eramet SA will be worth about 48.2 in December 2025. The stock is currently trading at 51.55. This means that the stock has a potential downside of -6.44%.
According to ValueRays Forecast Model, ERA Eramet SA will be worth about 48.2 in December 2025. The stock is currently trading at 51.55. This means that the stock has a potential downside of -6.44%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 88.8 | 72.3% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 48.2 | -6.4% |